Champions Oncology CSBR Estimates

NASDAQ CSBR
$5.19 +0.18 (+3.59%)
As of: Sep 10, 2026 · 9:34 AM EDT
Analyst Estimates

Champions Oncology, Inc. Revenue Estimates

Periods 16
Next Period Q1 26
Consensus 15.36 M

Analysts expect Champions Oncology, Inc. to report revenue of 15.36 M for Q1 26, against a range of 14.37 M to 16.35 M. The most recent reported quarter, Q4 25, came in at 13.84 M, a 1.0% beat against the 13.71 M consensus.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 14.10 M13.50 M17.04 M12.36 M13.99 M15.04 M16.56 M13.84 M--------
High Estimate 14.76 M13.36 M13.94 M13.47 M14.95 M15.57 M16.93 M14.66 M16.35 M16.52 M19.78 M16.63 M17.80 M19.27 M18.98 M18.63 M
Low Estimate 13.25 M11.85 M12.95 M11.47 M13.91 M13.12 M15.59 M12.76 M14.37 M14.65 M18.52 M13.96 M15.67 M16.89 M17.87 M16.53 M
Consensus Estimate 14.01 M12.61 M13.45 M12.47 M14.43 M14.35 M16.26 M13.71 M15.36 M15.59 M19.15 M15.30 M16.74 M18.08 M18.43 M17.58 M
Analyst Estimates

Champions Oncology, Inc. Earnings Per Share (EPS) Estimates

Periods 16
Next Period Q1 26
Consensus -0.01

Analysts expect Champions Oncology, Inc. to report earnings per share of -0.01 for Q1 26, against a range of -0.01 to -0.01. The most recent reported quarter, Q4 25, came in at 0.01, a 120.0% beat against the -0.05 consensus.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 0.110.050.36-0.070.020.06-0.020.01--------
High Estimate -0.030.01-0.01-0.20-0.010.000.08-0.05-0.010.020.080.01-0.02-0.010.00-0.03
Low Estimate -0.030.01-0.01-0.22-0.010.000.08-0.05-0.010.020.080.01-0.02-0.010.00-0.03
Consensus Estimate -0.030.01-0.01-0.21-0.010.000.08-0.05-0.010.020.080.01-0.02-0.010.00-0.03